Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer-Reference-Cited by-同舟云学术

Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer

Published:2013-11-13 Issue:2 Volume:73 Page:231-236
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Krzakowski M.,Bennouna J.,Dansin E.,Kowalski D.,Hiret S.,Penel N.,Favrel S.,Tourani J. M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-013-2342-3/fulltext.html

Reference12 articles.

1. Janssen-Heijnen ML, Gatta G, Forman D, Capocaccia R, Coebergh JW et al (1998) Variation in survival of patients with lung cancer in Europe, 1985-1989. Eur J Cancer 34:2191–2196

2. Felip E, Gridelli C, Baas P, Rosell R, Stahel R, Panel Members (2011) Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO consensus conference in lung cancer; Lugano 2010. Ann Oncol 22:1507–1519

3. Evans WK, Newman T, Graham I, Rusthoven JJ, Logan D et al (1997) Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site Group. J Clin Oncol 15:3049–3059

4. Noble J, Ellis PM, Mackay JA, Evans WK et al (2006) Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol 1:1042–1058

5. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH et al (2005) Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353:123–132

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer;Biomedicine & Pharmacotherapy;2017-12

2. Anti-mitotic agents: Are they emerging molecules for cancer treatment?;Pharmacology & Therapeutics;2017-05

3. Vinflunine for the treatment of non-small cell lung cancer;Expert Opinion on Investigational Drugs;2016-11

4. Vinca alkaloids;Meyler's Side Effects of Drugs;2016